Through the ID YOUR IRD gene testing initiative, Spark Therapeutics aspires to help people living with certain inherited retinal diseases (IRDs) by providing access to genetic information that can empower their decisions. This initiative is open to U.S. residents only.
Participation in the ID YOUR IRD gene testing initiative is subject to the terms and conditions of the program. Participants will receive genetic testing and optional, confidential genetic counseling sessions at no cost to them regardless of their insurance status. Although participants will not pay for the costs of genetic testing offered by the initiative or the optional genetic counseling, participants are responsible for any other costs they may incur, such as doctor's visits.